The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Comparison of cardiac computed tomography angiography and transoesophageal echocardiography for device surveillance after left atrial appendage closure. What we see depends on where we are looking from and what we are looking for

EuroIntervention 2019;15:650-651. DOI: 10.4244/EIJV15I8A119

1. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA


Left atrial appendage occlusion (LAAO) for the prevention of cardioembolic strokes in patients with non-valvular atrial fibrillation (NVAF) is being performed with increasing frequency1,2. Although there is only one device approved in the USA, European and other countries have the advantage that several devices are either undergoing clinical testing or are already approved. As the field evolves, now that procedural safety issues have been largely resolved and long-term efficacy established, two items have become of increasing concern – device-related thrombus (DRT) and residual leak. Both were described early in the field but have now been accorded more interest because ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Frailty in patients undergoing TAVI: how can we measure it?